The inhibition of islet superoxide dismutase by diabetogenic drugs.
D000496:Alloxan / Q000494:pharmacology*; D000818:Animals; D002417:Cattle; D003921:Diabetes Mellitus, Experimental / Q000201:enzymology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000201:enzymology; D006801:Humans; D007515:Islets of Langerhans / Q000201:enzymology*; D007700:Kinetics; D008297:Male; D008930:Mitochondria, Liver / Q000201:enzymology; D010671:Phenylurea Compounds / Q000494:pharmacology*; D051381:Rats; D013311:Streptozocin / Q000494:pharmacology*; D013482:Superoxide Dismutase / Q000037:antagonists & inhibitors*
D010671:Phenylurea Compounds; D013311:Streptozocin; D000496:Alloxan; D013482:Superoxide Dismutase; C012598:pyriminil